Mackenzie Financial’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,298
Closed -$60.3K 1485
2025
Q4
$60.3K Sell
25,298
-866
-3% -$2.37K ﹤0.01% 1614
2025
Q3
$80.1K Buy
+26,164
New +$74.7K ﹤0.01% 1640
2025
Q1
Sell
-78,193
Closed -$246K 1703
2024
Q4
$246K Buy
78,193
+53,076
+211% +$190K ﹤0.01% 1466
2024
Q3
$70.8K Buy
+25,117
New +$57.5K ﹤0.01% 1515
2023
Q2
Sell
-24,649
Closed -$20.8K 1530
2023
Q1
$20.8K Hold
24,649
﹤0.01% 1483
2022
Q4
$22.9K Hold
24,649
﹤0.01% 1394
2022
Q3
$42K Sell
24,649
-1,409
-5% -$3.69K ﹤0.01% 1366
2022
Q2
$56K Buy
+26,058
New +$69.3K ﹤0.01% 1385

Other funds holding CLOV

Mackenzie Financial's CLOV Position: Q1 2026 in Review

Mackenzie Financial sold out of Clover Health Investments (CLOV) in Q1 2026, closing a stake of 25,298 shares — an estimated $60.3K sold.

Mackenzie Financial first reported a position in CLOV in Q2 2022 and held it in 8 quarters. The position peaked at $246K in Q4 2024. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Mackenzie Financial reported no remaining Clover Health Investments position as of Q1 2026 after selling out during the quarter.
  • Mackenzie Financial sold 25,298 Clover Health Investments shares in Q1 2026, an estimated $60.3K.
  • Mackenzie Financial first reported a position in Clover Health Investments in Q2 2022 and held it in 8 quarters.
  • Mackenzie Financial's Clover Health Investments position peaked at $246K in Q4 2024.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.